Recently, Audrito et al. showed that patients with BRAF-mutated melanoma have increased NAMPT mRNA and protein levels more than the BRAF-wild type ones [171], indicating a direct molecular link between a driver oncogenic signaling and the regulation of the expression of this enzyme. Here, NAMPT is linked to melanoma.